Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KDM4A | O75164 | 1/20 | 0.32 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.30 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.30 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.30 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.30 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.30 |
| ▸ | HTR1B | P28222 | 1/20 | 0.30 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
| ▸ | HRH1 | P35367 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5142057 | 1.00 | EPHX1 (0.55) | EPHX1SIGMAR1PAOXL3MBTL1KDM4A | |
| SCHEMBL6235646 | 1.00 | EPHX1 (0.55) | EPHX1SIGMAR1PAOXL3MBTL1KDM4A | |
| SCHEMBL16892582 | 1.00 | EPHX1 (0.55) | EPHX1SIGMAR1PAOXL3MBTL1KDM4A | |
| SCHEMBL7453221 | 1.00 | EPHX1 (0.55) | EPHX1SIGMAR1PAOXL3MBTL1KDM4A | |
| SCHEMBL198272 | 1.00 | — | — | |
| SCHEMBL1770447 | 1.00 | EPHX1 (0.55) | EPHX1SIGMAR1PAOXL3MBTL1KDM4A | |
| SCHEMBL997426 | 1.00 | — | — | |
| SCHEMBL5073915 | 1.00 | EPHX1 (0.55) | EPHX1SIGMAR1PAOXL3MBTL1KDM4A | |
| SCHEMBL5246477 | 1.00 | EPHX1 (0.55) | EPHX1SIGMAR1PAOXL3MBTL1KDM4A | |
| SCHEMBL434754 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4710491-A | N-glycosylated carboxylic acid derivatives as agents for combating rheumatic diseases | TROPONWERKE GMBH & CO., KG (DE) | 1987-12-01 | — | — | US | claimed |
| EP-2894685-B1 | BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR | DAINIPPON INK & CHEMICALS (JP) | 2018-10-31 | — | — | EP | disclosed |
| US-9490433-B2 | Benzothienobenzothiophene derivative, organic semiconductor material, and organic transistor | DIC CORPORATION (JP) | 2016-11-08 | — | — | US | disclosed |
| US-20150228913-A1 | BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR | DIC CORPORATION (JP) | 2015-08-13 | — | — | US | disclosed |
| EP-2894685-A1 | BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR | DIC Corporation (JP) | 2015-07-15 | — | — | EP | disclosed |
| EP-1379598-B1 | UNSATURATED COMPOUNDS CONTAINING CARBAMATE TERMINAL GROUPS OR UREA TERMINAL GROUPS | BASF AG (DE) | 2007-09-12 | — | — | EP | disclosed |
| US-6916854-B2 | Heat and/or light curable films or coatings comprising polyurethanes or polyureaurethane copolymers having storage stability, used as automobile paints | BASF AKTIENGESELLSCHAFT (DE) | 2005-07-12 | — | — | US | disclosed |
| US-20040097642-A1 | Unsaturated compounds containing carbamate terminal groups or urea terminal groups | BASF AKTIENGESELLSCHAFT (DE) | 2004-05-20 | — | — | US | disclosed |
| EP-1379598-A1 | UNSATURATED COMPOUNDS CONTAINING CARBAMATE TERMINAL GROUPS OR UREA TERMINAL GROUPS | BASF AKTIENGESELLSCHAFT (DE) | 2004-01-14 | — | — | EP | disclosed |
| WO-2002086000-A1 | UNSATURATED COMPOUNDS CONTAINING CARBAMATE TERMINAL GROUPS OR UREA TERMINAL GROUPS | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-31 | — | — | WO | disclosed |
| US-4574122-A | ANTIBODIES, IMMUNOLOGY | BAYER AKTIENGESELLSCHAFT (DE) | 1986-03-04 | — | — | US | disclosed |
| EP-0155625-A2 | Glycolipid-like substances in liposome form | BAYER AG (DE) | 1985-09-25 | — | — | EP | disclosed |
| EP-0152856-A2 | N-acylated 1-alkylamimo-1-desoxy ketose derivatives, method for their preparation and use | BAYER AG (DE) | 1985-08-28 | — | — | EP | disclosed |
| EP-0149760-A2 | Substituted O-acyl glycosylamides, methods for their preparation and their use | BAYER AG (DE) | 1985-07-31 | — | — | EP | disclosed |
| EP-0149093-A2 | N-glycosylated ureas, carbamates and thiocarbamates, their preparation method and their use | BAYER AG (DE) | 1985-07-24 | — | — | EP | disclosed |
| EP-0147777-A2 | Derivatives of M-glycosylated amides of carboxylic acids as a product for combating diseases of the rheumatism type | Troponwerke GmbH & Co. KG (DE) | 1985-07-10 | — | — | EP | disclosed |
| EP-0144894-A2 | Therapeutic application of substituted O-acyl-glycosides | BAYER AG (DE) | 1985-06-19 | — | — | EP | disclosed |
| EP-0143385-A2 | Phosphorylised glycosil amides, ureas, carbamates and thiocarbamates, method for their preparation and their use | BAYER AG (DE) | 1985-06-05 | — | — | EP | disclosed |
| EP-0140321-A2 | Use of derivatives of amides of carboxylic acids in which the N atom is substituted by a glycosyl radical as growth promotor in animal nutrition | BAYER AG (DE) | 1985-05-08 | — | — | EP | disclosed |
| EP-0091645-A1 | Derivatives of amides of carboxylic acids in which the N atom is substituted by a glycosyl radical, method for their preparation and their use to influence the immunogenic system | BAYER AG (DE) | 1983-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150228913-A1 | BENZOTHIENOBENZOTHIOPHENE DERIVATIVE, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC TRANSISTOR | TST, TPST2, TPR | EPHX1 3457/4885SIGMAR1 3454/4885PAOX 1929/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.